Canopy Growth Corp SEC filings CGC
Canopy Growth Corp has 763 filings in SEC EDGAR's recent list, going back to May 16, 2018. Its latest annual report, Form ARS, was filed on Aug 7, 2026 for the period ended Mar 31, 2026. The latest quarterly report (Form 10-Q) was filed on Aug 7, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 23, 2026 (shareholder vote results). The company's fiscal year ends on March 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEFA14A | Additional proxy material | Oct 16, 2026 | — |
| DEFA14A | Additional proxy material | Oct 6, 2026 | — |
| DEFA14A | Additional proxy material | Sep 25, 2026 | — |
| DEFA14A | Additional proxy material | Sep 15, 2026 | — |
| DEFA14A | Additional proxy material | Aug 17, 2026 | — |
| DEFA14A | Additional proxy material | Aug 14, 2026 | — |
| DEFA14A | Additional proxy material | Aug 7, 2026 | — |
| DEF 14A | Proxy statement | Aug 7, 2026 | Sep 25, 2026 |
| PRE 14A | Preliminary proxy statement | Jul 17, 2026 | Sep 25, 2026 |
| DEFA14A | Additional proxy material | Sep 26, 2025 | — |
| DEFA14A | Additional proxy material | Sep 24, 2025 | — |
| DEFA14A | Additional proxy material | Sep 19, 2025 | — |
| DEFA14A | Additional proxy material | Sep 3, 2025 | — |
| DEFA14A | Additional proxy material | Aug 19, 2025 | — |
| DEFA14A | Additional proxy material | Aug 19, 2025 | — |
| DEFA14A | Additional proxy material | Aug 15, 2025 | — |
| DEFA14A | Additional proxy material | Aug 7, 2025 | — |
| DEF 14A | Proxy statement | Aug 7, 2025 | Sep 26, 2025 |
| PRE 14A | Preliminary proxy statement | Jul 25, 2025 | Sep 26, 2025 |
| DEFA14A | Additional proxy material | Sep 23, 2024 | — |
| DEFA14A | Additional proxy material | Sep 16, 2024 | — |
| DEFA14A | Additional proxy material | Sep 13, 2024 | — |
| DEFA14A | Additional proxy material | Sep 11, 2024 | — |
| DEFA14A | Additional proxy material | Aug 23, 2024 | — |
| DEFA14A | Additional proxy material | Aug 16, 2024 | — |
| DEFA14A | Additional proxy material | Aug 13, 2024 | — |
| DEFA14A | Additional proxy material | Aug 13, 2024 | — |
| DEFA14A | Additional proxy material | Aug 1, 2024 | — |
| DEF 14A | Proxy statement | Aug 1, 2024 | Sep 24, 2024 |
| DEFA14A | Additional proxy material | Apr 1, 2024 | — |
| DEFA14A | Additional proxy material | Mar 14, 2024 | — |
| DEFA14A | Additional proxy material | Mar 11, 2024 | — |
| DEFA14A | Additional proxy material | Mar 11, 2024 | — |
| DEFA14A | Additional proxy material | Mar 1, 2024 | — |
| DEFA14A | Additional proxy material | Feb 26, 2024 | — |
| DEFA14A | Additional proxy material | Feb 21, 2024 | — |
| DEFA14A | Additional proxy material | Feb 20, 2024 | — |
| DEFA14A | Additional proxy material | Feb 13, 2024 | — |
| DEF 14A | Proxy statement | Feb 12, 2024 | Apr 12, 2024 |
| DEFA14A | Additional proxy material | Feb 9, 2024 | — |
| DEFA14A | Additional proxy material | Sep 11, 2023 | — |
| DEFA14A | Additional proxy material | Aug 9, 2023 | — |
| DEF 14A | Proxy statement | Aug 9, 2023 | Sep 25, 2023 |
| PRE 14A | Preliminary proxy statement | Jul 14, 2023 | Sep 25, 2023 |
| DEFA14A | Additional proxy material | Jul 14, 2023 | — |
| DEFA14A | Additional proxy material | May 22, 2023 | — |
| DEFA14A | Additional proxy material | Oct 31, 2022 | — |
| DEFA14A | Additional proxy material | Oct 31, 2022 | — |
| DEFA14A | Additional proxy material | Oct 27, 2022 | — |
| DEFA14A | Additional proxy material | Oct 27, 2022 | — |
| DEFA14A | Additional proxy material | Oct 27, 2022 | — |
| DEFA14A | Additional proxy material | Oct 27, 2022 | — |
| DEFA14A | Additional proxy material | Oct 27, 2022 | — |
| DEFA14A | Additional proxy material | Oct 26, 2022 | — |
| DEFA14A | Additional proxy material | Oct 26, 2022 | — |
| DEFA14A | Additional proxy material | Oct 25, 2022 | — |
| DEFA14A | Additional proxy material | Oct 25, 2022 | — |
| DEFA14A | Additional proxy material | Oct 25, 2022 | — |
| DEFA14A | Additional proxy material | Oct 25, 2022 | — |
| DEFA14A | Additional proxy material | Oct 25, 2022 | — |
| PRE 14A | Preliminary proxy statement | Oct 25, 2022 | Oct 25, 2022 |
| DEFA14A | Additional proxy material | Jul 29, 2022 | — |
| DEF 14A | Proxy statement | Jul 29, 2022 | Sep 15, 2022 |
| DEFA14A | Additional proxy material | Jul 29, 2021 | — |
| DEF 14A | Proxy statement | Jul 29, 2021 | Sep 14, 2021 |
| PRE 14A | Preliminary proxy statement | Jul 12, 2021 | Sep 14, 2021 |
| DEFA14A | Additional proxy material | Aug 7, 2020 | — |
| DEF 14A | Proxy statement | Aug 7, 2020 | Sep 21, 2020 |
Showing 68 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Medicinal Chemicals & Botanical Products (SIC 2833)
- Listed as
- CGC (Nasdaq)
- Fiscal year ends
- March 31
- Incorporated in
- Canada (Federal Level)
- Headquarters
- Smith Falls, Ontario, Canada
- SEC filer status
- Accelerated filer
- SEC CIK
- 1737927
Other Medicinal Chemicals & Botanical Products companies
- Definium Therapeutics, Inc. DFTX
- Regencell Bioscience Holdings Ltd RGC
- Curaleaf Holdings, Inc. CURLF
- Trulieve Cannabis Corp. TRLV
- Cronos Group Inc. CRON
- TFA Therapeutics, Inc. RAJAF
- Tilray Brands, Inc. TLRY
- SNDL Inc. SNDL
Source: SEC EDGAR filings. This is company-reported data, not investment advice.